Cargando…
Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131)
OBJECTIVE: Palonosetron is effective for the management of acute and delayed chemotherapy-induced nausea and vomiting (CINV). While emetogenic carboplatin-based chemotherapy is widely used to treat gynecologic cancers, few studies have evaluated the antiemetic effectiveness of palonosetron in this s...
Autores principales: | Nishio, Shin, Aihara, Satomi, Shimokawa, Mototsugu, Fujishita, Akira, Taniguchi, Shuichi, Hachisuga, Toru, Yanazume, Shintaro, Kobayashi, Hiroaki, Murakami, Fumihiro, Numa, Fumitaka, Kotera, Kohei, Okura, Naofumi, Toki, Naoyuki, Yokoyama, Masatoshi, Ushijima, Kimio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078893/ https://www.ncbi.nlm.nih.gov/pubmed/30022637 http://dx.doi.org/10.3802/jgo.2018.29.e77 |
Ejemplares similares
-
Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
por: Fujiwara, Satoe, et al.
Publicado: (2015) -
Chemotherapy of Gynecologic Cancer
por: Osborne, R.
Publicado: (1991) -
Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment
por: Kunitake, Teruyo, et al.
Publicado: (2020) -
Arginine vasopressin--a mediator of chemotherapy induced emesis?
por: Edwards, C. M., et al.
Publicado: (1989) -
Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant
por: Olver, Ian, et al.
Publicado: (2007)